NICHOLAS CARTE: Open Payments
NPI 1285032979 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 60 payments from 11 companies in 2025. Trend: 2023 $686 · 2024 $1,152 · 2025 $2,246
Food & beverage: $2,246
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $579 |
| Vanda Pharmaceuticals Inc. | 16 | $488 |
| Otsuka America Pharmaceutical, Inc. | 8 | $259 |
| Axsome Therapeutics, Inc. | 5 | $214 |
| ABBVIE INC. | 9 | $202 |
| Alkermes, Inc. | 3 | $165 |
| E.R. Squibb & Sons, L.L.C. | 6 | $156 |
| Novo Nordisk Inc | 1 | $115 |
| Indivior Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
Products named: CAPLYTA, FANAPT, REXULTI, Auvelity, VRAYLAR, HETLIOZ, COBENFY, LYBALVI.
Industry payments across NC — which companies pay providers there.
